Acerus Pharmaceuticals Corp — Form D

Acerus Pharmaceuticals Corp of MISSISSAUGA, A6, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-03. The offering totals $12.0M, of which $6.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Bruce D BrydonDirectorMississauga, A6
James L ButlerDirectorMississauga, A6
Larry L DavisDirectorPhoenix, AZ
Douglas L DeethDirectorMississauga, A6
Stephen L GregoryDirectorMississauga, A6
Robert L PodruznyDirectorMississauga, A6
Rolf L ReininghausDirectorMississauga, A6
Jeffrey L ShermanDirectorMississauga, A6
Bruce D BrydonExecutive OfficerMississauga, A6
Kenneth G HowlingExecutive OfficerMississauga, A6
Rolf L ReininghausExecutive OfficerMississauga, A6
Mark L ThompsonExecutive OfficerMississauga, A6
Eugene L MelnykPromoterSt. Philip, C8
Nathan BrysonExecutive OfficerMorristown, NJ
Matthew HawkinsExecutive OfficerToronto, A6
Tom RossiDirectorBuffalo, NY
Tom RossiExecutive OfficerBuffalo, NY
Ian IhnatowyczDirectorVancouver, A1
Matthew K HawkinsExecutive OfficerFORT LEE, NJ
BORYS K CHABURSKYDirectorMISSISSAUGA, A6
ROLF K REININGHAUSDirectorMISSISSAUGA, A6
ROLF K REININGHAUSExecutive OfficerMISSISSAUGA, A6
TOM K ROSSIDirectorMISSISSAUGA, A6
TOM K ROSSIExecutive OfficerMISSISSAUGA, A6
JEFFREY K SHERMANDirectorMISSISSAUGA, A6

Other filings by this issuer (2)

FiledFormOfferingSold
2016-05-05D$2.0M$2.0M
2014-08-13D$2.1M$2.1M

More